{"name": "Omthera Pharmaceuticals",
 "permalink": "omthera-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/omthera-pharmaceuticals",
 "homepage_url": "http://www.omthera.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "908-741-4399",
 "description": "Clinical Stage BioPharma Company",
 "created_at": "Tue Mar 30 06:57:26 UTC 2010",
 "updated_at": "Fri Aug 05 02:04:33 UTC 2011",
 "overview": "\u003Cp\u003EOmthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       61],
      "assets/images/resized/0008/2359/82359v2-max-150x150.jpg"],
     [[250,
       102],
      "assets/images/resized/0008/2359/82359v2-max-250x250.jpg"],
     [[266,
       109],
      "assets/images/resized/0008/2359/82359v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO, Board Member, Co-Founder",
    "person":
     {"first_name": "Jerry",
      "last_name": "Wisler",
      "permalink": "jerry-wisler",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer, Co-Founder",
    "person":
     {"first_name": "Michael",
      "last_name": "H. Davidson",
      "permalink": "michael-h-davidson",
      "image": null}},
   {"is_past": false,
    "title": "Executive Vice President and CFO",
    "person":
     {"first_name": "Christian",
      "last_name": "S. Schade",
      "permalink": "christian-s-schade",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "David",
      "last_name": "Mott",
      "permalink": "david-mott",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$40.4M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/omthera-pharmaceuticals-inc-series-a-65m/",
    "source_description": "Omthera Pharmaceuticals, Inc.: Series A $6.5M",
    "raised_amount": 6500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sofinnova Partners",
         "permalink": "sofinnova-partners",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/4451/44451v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0004/4451/44451v1-max-250x250.jpg"],
             [[321,
               43],
              "assets/images/resized/0004/4451/44451v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/omthera-rounds-34m-series-b-adds-david-mott-board/2011-03-14?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Omthera rounds up $34M in Series B, adds David Mott to board",
    "raised_amount": 33900000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 3,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Enterprise Associates",
         "permalink": "new-enterprise-associates",
         "image":
          {"available_sizes":
            [[[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-150x150.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-250x250.png"],
             [[150,
               110],
              "assets/images/resized/0001/5083/15083v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Partners",
         "permalink": "sofinnova-partners",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/4451/44451v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0004/4451/44451v1-max-250x250.jpg"],
             [[321,
               43],
              "assets/images/resized/0004/4451/44451v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 443000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.worldpharmanews.com/astrazeneca/2450-astrazeneca-to-acquire-omthera-pharmaceuticals-including-nda-ready-novel-dyslipidemia-treatment-to-complement-cardiovascular-portfolio",
   "source_description": "AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio ",
   "acquired_year": 2013,
   "acquired_month": 5,
   "acquired_day": 29,
   "acquiring_company":
    {"name": "AstraZeneca",
     "permalink": "astrazeneca",
     "image":
      {"available_sizes":
        [[[150,
           37],
          "assets/images/resized/0006/4083/64083v1-max-150x150.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-250x250.png"],
         [[176,
           44],
          "assets/images/resized/0006/4083/64083v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Bedminster",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        89],
       "assets/images/resized/0012/6329/126329v1-max-150x150.jpg"],
      [[250,
        148],
       "assets/images/resized/0012/6329/126329v1-max-250x250.jpg"],
      [[450,
        267],
       "assets/images/resized/0012/6329/126329v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}